Summary
Overview
Work History
Education
Skills
Certification
Timeline
Generic
Mangesh Deotale

Mangesh Deotale

Commercial Leader | Portfolio Strategy & P&L | Strategic Partnerships | Cross-Functional Business Growth | Team Leadership
Hyderabad,TS

Summary

Commercial leader with 14+ years in pharmaceutical marketing and portfolio management across Oncology, Hematology, Osteoporosis, Specialty Care and Cardiovascular. Currently owns commercial strategy, pricing, forecasting and P&L for a ₹200+ crore specialty portfolio at Dr. Reddy's Laboratories. Track record of executing global in-licensing and partnerships — most recently with Amgen — from deal execution through commercial launch and market entry planning, and of coordinating cross-functional teams (Medical, Market Access, Regulatory, Sales) to deliver business plans and lifecycle strategy. Experienced people leader who sets KPIs, coaches performance and builds commercial capability within teams.

Overview

2
2
Certifications
14
14
years of professional experience

Work History

Group Marketing Manager – Breast Cancer & Hematology

Dr. Reddy's Laboratories
02.2025 - Current
  • Grew / stabilized a ₹200+ crore oncology portfolio (breast cancer & hematology) to 23% vs. prior year through end-to-end ownership of commercial strategy, pricing, forecasting and P&L.
  • Built and led a 5-member Brand Manager team, lifting KPI attainment to 100% through structured coaching, target-setting and conflict resolution.
  • Aligned annual business plans with Medical, Market Access, Regulatory and Sales, cutting go-to-market cycle time across the portfolio.
  • Led commercial planning and launch execution for the Pertuzumab biosimilar, driving 28% market share / ₹55 Cr revenue within 11 months of launch.
  • Integrated CRM insights with sales and marketing planning, enhancing customer targeting accuracy and increasing ROI of promotional campaigns by 30%.
  • Built a customer-centric insights ecosystem by integrating market research, KOL advisory boards, FGDs, CRM analytics, and field intelligence, enabling sharper segmentation, stronger value propositions, and data-driven decisions that accelerated portfolio growth and launch success.
  • Pioneered a comprehensive WOMAB Patient Support Program encompassing patient education, treatment adherence, wellness support, counselling, and treatment navigation, improving therapy continuity, patient experience, and brand differentiation.
  • Awarded Dr. Reddy's Marketing Excellence Award for building WOMAB into the company's fastest-growing ₹50 Cr brand and driving sustained leadership of the Hematology business as the No. 1 Division.

Group Therapy Manager – Osteoporosis & Osteoarthritis

Dr. Reddy's Laboratories
01.2024 - 02.2025
  • Led the Innovator launch of EVENITY (Romosozumab), delivering 110% of launch-year target ₹20 Cr in year-one sales through a self-designed commercialization strategy.
  • Grew EVENITY's share of the osteoporosis segment to 5% within 12 months of launch, outperforming category growth of division by 30%.
  • Acted as primary commercial counterpart to Amgen's global partner teams, aligning launch readiness and forecasting, cutting time-to-launch by 25% vs. plan.
  • Built the competitive positioning and market entry plan for a novel therapy class, converting 110 of targeted physician base within the first 12 months.
  • Awarded Dr. Reddy's Marketing Excellence Award for EVENITY in best-in-class INNOVATOR launch category, in parallel also received No:1 Division Award in Specialty segment (OSTEOZEN)

Group Product Manager

Dr. Reddy's Laboratories
12.2018 - 12.2023
  • Developed brand strategy, pricing and lifecycle plans across a multi-brand specialty portfolio, growing combined revenue by 25% for the brand – Brand Handled DOXT-SL, portfolio size 140 Cr
  • Directed digital marketing campaigns that grew customer/HCP reach by 50% and engagement by 25%, through >4 Touchpoints
  • Enabled a 600-member field force with brand strategy, market positioning and customer-facing tools, contributing to 23% improvement in field productivity / call effectiveness for Mature brands

Senior Brand Manager

Glenmark Pharmaceuticals
06.2018 - 11.2018
  • Led Dermatology portfolio strategy and commercial launch of APREZO, achieving >100% of launch target within 12 months.

Senior Brand Manager

Aristo Pharmaceuticals
07.2014 - 05.2018
  • Managed commercial strategy for Cardiovascular brands (Nebivolol, Telmisartan), growing combined brand revenue by 20% over 3 years.
  • Led the GTM strategy for TELVAS, brand of Telmisartan, scaling to 100 Cr in 2018 from 85 Cr in 20215

Product Manager

Ipca Laboratories
03.2012 - 06.2014
  • Developed brand strategy and commercial plans, Prescriber base & P/D centric campaigns for the assigned portfolio.

Education

MBA - Healthcare & Pharma Management

IES Management College & Research Centre
Mumbai, India

Bachelor of Pharmacy (B.Pharm) -

Vidya Bharti College of Pharmacy
Amravati, India

Skills

Commercial strategy & portfolio planning

P&L ownership & commercial forecasting

Product pricing & lifecycle management

Global partnership & in-licensing execution

Product launch & market entry planning

Market research & insights

Customer segmentation

KOL engagement

Digital marketing strategy

Field force enablement

Certification

Oracle Eloqua

Timeline

Group Marketing Manager – Breast Cancer & Hematology

Dr. Reddy's Laboratories
02.2025 - Current

Group Therapy Manager – Osteoporosis & Osteoarthritis

Dr. Reddy's Laboratories
01.2024 - 02.2025

Group Product Manager

Dr. Reddy's Laboratories
12.2018 - 12.2023

Senior Brand Manager

Glenmark Pharmaceuticals
06.2018 - 11.2018

Senior Brand Manager

Aristo Pharmaceuticals
07.2014 - 05.2018

Product Manager

Ipca Laboratories
03.2012 - 06.2014

MBA - Healthcare & Pharma Management

IES Management College & Research Centre

Bachelor of Pharmacy (B.Pharm) -

Vidya Bharti College of Pharmacy
Mangesh DeotaleCommercial Leader | Portfolio Strategy & P&L | Strategic Partnerships | Cross-Functional Business Growth | Team Leadership